These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1115749)

  • 1. Therapeutic studies in NZB/W mice. III. Relationship between renal status and efficacy of immunosuppressive drug therapy.
    Steinberg AD; Gelfand MC; Hardin JA; Lowenthal DT
    Arthritis Rheum; 1975; 18(1):9-14. PubMed ID: 1115749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic studies in NZB-W mice. I. Synergy of azathioprine, cyclophosphamide and methylprednisolone in combination.
    Gelfand MC; Steinberg AD; Nagle R; Knepshield JH
    Arthritis Rheum; 1972; 15(3):239-46. PubMed ID: 5031608
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic studies in NZB-W mice. II. Relative efficacy of azathioprine, cyclophosphamide and methylprednisolone.
    Gelfand MC; Steinberg AD
    Arthritis Rheum; 1972; 15(3):247-52. PubMed ID: 5031609
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic studies in NZB/W mice. IV. Effect of combination drug therapy on immune complex deposition.
    Gelfand MC; Schur PH; Asofsky R; Steinberg AD
    Arthritis Rheum; 1976; 19(1):43-8. PubMed ID: 130136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin-dependent kinase inhibition limits glomerulonephritis and extends lifespan of mice with systemic lupus.
    Zoja C; Casiraghi F; Conti S; Corna D; Rottoli D; Cavinato RA; Remuzzi G; Benigni A
    Arthritis Rheum; 2007 May; 56(5):1629-37. PubMed ID: 17469145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of cyclophosphamide and other immunosuppressive drugs on immune disorders and neoplasia in NZB/NZW mice.
    Hahn BH; Knotts L; Ng M; Hamilton TR
    Arthritis Rheum; 1975; 18(2):145-52. PubMed ID: 1131283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oncogenic effect of immunosuppressive (cytotoxic) agents in (NZB X NZW) mice. I. Long-term treatment with azathioprine and ifosfamide.
    Mitrou PS; Fischer M; Mitrou G; Röttger P; Holtz G
    Arzneimittelforschung; 1979; 29(3):483-8. PubMed ID: 314806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single and multiple drug therapy in autologous immune complex nephritis in rats.
    Kupor LR; Lowance DC; McPhaul JJ
    J Lab Clin Med; 1976 Jan; 87(1):27-36. PubMed ID: 128575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutting edge: reversal of murine lupus nephritis with CTLA4Ig and cyclophosphamide.
    Daikh DI; Wofsy D
    J Immunol; 2001 Mar; 166(5):2913-6. PubMed ID: 11207238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.
    Grootscholten C; Ligtenberg G; Hagen EC; van den Wall Bake AW; de Glas-Vos JW; Bijl M; Assmann KJ; Bruijn JA; Weening JJ; van Houwelingen HC; Derksen RH; Berden JH;
    Kidney Int; 2006 Aug; 70(4):732-42. PubMed ID: 16820790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of lupus nephritis.
    Pollak VE
    Adv Nephrol Necker Hosp; 1976; 6():137-61. PubMed ID: 828444
    [No Abstract]   [Full Text] [Related]  

  • 12. Ribavirin treatment in murine autoimmune disease. I. Therapeutic efficacy and effect on the immune response.
    Klassen LW; Williams GW; Reinertsen JL; Gerber NL; Steinberg AD
    Arthritis Rheum; 1979 Feb; 22(2):145-54. PubMed ID: 33680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Instructions and implementations for percutaneous renal biopsy. Guidelines for the therapy of glomerular nephropaties].
    Cagnoli L;
    G Ital Nefrol; 2003; 20 Suppl 24():S3-47. PubMed ID: 14666502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy with pulse methylprednisolone and short course pulse cyclophosphamide for diffuse proliferative glomerulonephritis.
    Mosca M; Neri R; Giannessi S; Pasquariello A; Puccini R; Bencivelli W; Bombardieri S
    Lupus; 2001; 10(4):253-7. PubMed ID: 11341101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cyclophosphamide pulse therapy in patients with primary glomerulonephritis].
    Rutkowski B; Wielgosz A; Manitius J; Bułło B; Kowalewska J; Tylicki L; Roszkiewicz A
    Przegl Lek; 2000; 57(11):624-7. PubMed ID: 11293209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceleration of glomerulonephritis in NZB x NZW mice by early immunization with DNA and injection of bacterial lipopolysaccharide. Experimental approach to the treatment of lupus nephritis by use of the accelerated model of NZB x NZW mouse disease.
    Fournie GJ; Minh MG; Mignon-Conte MA; Hass S; Lambert PH; Conte JJ
    J Clin Lab Immunol; 1980 Sep; 4(2):103-6. PubMed ID: 7441709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Pulse' methylprednisolone and cyclophosphamide therapy in idiopathic rapidly progressive glomerulonephritis.
    Friedman G; Granot H; Koplovic Y; Friedlander M
    Postgrad Med J; 1981 Jan; 57(663):54-6. PubMed ID: 7279827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Unilaterally nephrectomized NZB hybrids as test objects for immunosuppressive (antiglomerulonephritic) agents].
    Güttner J; Augsten K
    Z Versuchstierkd; 1972; 14(5):263-70. PubMed ID: 4634270
    [No Abstract]   [Full Text] [Related]  

  • 19. Methylprednisolone and cyclophosphamide pulse therapy in crescentic glomerulonephritis: safety and effectiveness.
    Rondeau E; Kourilsky O; Peraldi MN; Alberti C; Kanfer A; Sraer JD
    Ren Fail; 1993; 15(4):495-501. PubMed ID: 8210561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic lupus erythematosus--immunoregulatory therapies.
    Miller ML; Steinberg AD
    Clin Rheum Dis; 1983 Dec; 9(3):617-28. PubMed ID: 6360516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.